Scholarlink

Background <p>The early identification of patients with sepsis among those presenting with suspected infection in the emergency department (ED) remains challenging. Delta-like canonical Notch ligand-1 (DLL-1), a Notch pathway ligand involved in immune and endothelial signaling, has been shown to reflect disease severity and outcomes in ICU-based sepsis cohorts. Its value for early risk stratification at ED presentation is less well defined.</p> Methods <p>We analyzed DLL-1 concentrations in serum samples from a prospectively enrolled ED cohort of adults presenting with clinically suspected acute infection. Blood samples were obtained during the initial clinical assessment. Sepsis was defined according to Sepsis-3 criteria and adjudicated by an expert panel, including evaluation of organ dysfunction within 72&#xa0;h after presentation. DLL-1 concentrations were measured using enzyme-linked immunosorbent assay (ELISA), and diagnostic performance was assessed using AUROC analysis.</p> Results <p>Among 300 enrolled patients, 74 (24.7%) were classified as having sepsis. DLL-1 concentrations were significantly higher in patients with sepsis than in those without sepsis (median 11,454 vs. 8,085&#xa0;pg/mL; p &lt; 0.001). DLL-1 demonstrated moderate discriminatory performance for sepsis at ED presentation (AUROC 0.69, 95% CI 0.62–0.76). Performance was lower than that of procalcitonin and NEWS2 but comparable to C-reactive protein and lactate. DLL-1 showed a moderate correlation with SOFA score. Importantly, correlations with CRP and white blood cell count were nonsignificant.</p> Conclusions <p>When measured at ED presentation, DLL-1 concentrations are elevated in patients with sepsis but showed only moderate diagnostic performance. These findings are consistent with earlier disease stages and lower degrees of organ dysfunction compared with ICU populations. DLL-1 may offer complementary host-response information beyond established biomarkers, but does not support stand-alone use for early sepsis diagnosis and warrants further evaluation within multimodal risk stratification strategies.</p> <p>Trial registration.</p> <p>DRKS00017395.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

From bench to triage: diagnostic utility of delta-like canonical notch ligand-1 (DLL-1) for early sepsis prediction in the emergency department

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月13日

查看全文
  • Aurelia Hübner,
  • Katharina Friedrich,
  • Noa Galtung,
  • Vivienne Theobald,
  • Judith Schenz,
  • Britta Hecke,
  • Melanie Kraß,
  • Markus A. Weigand,
  • Kai Kappert,
  • Wolfgang Bauer

摘要

Background

The early identification of patients with sepsis among those presenting with suspected infection in the emergency department (ED) remains challenging. Delta-like canonical Notch ligand-1 (DLL-1), a Notch pathway ligand involved in immune and endothelial signaling, has been shown to reflect disease severity and outcomes in ICU-based sepsis cohorts. Its value for early risk stratification at ED presentation is less well defined.

Methods

We analyzed DLL-1 concentrations in serum samples from a prospectively enrolled ED cohort of adults presenting with clinically suspected acute infection. Blood samples were obtained during the initial clinical assessment. Sepsis was defined according to Sepsis-3 criteria and adjudicated by an expert panel, including evaluation of organ dysfunction within 72 h after presentation. DLL-1 concentrations were measured using enzyme-linked immunosorbent assay (ELISA), and diagnostic performance was assessed using AUROC analysis.

Results

Among 300 enrolled patients, 74 (24.7%) were classified as having sepsis. DLL-1 concentrations were significantly higher in patients with sepsis than in those without sepsis (median 11,454 vs. 8,085 pg/mL; p < 0.001). DLL-1 demonstrated moderate discriminatory performance for sepsis at ED presentation (AUROC 0.69, 95% CI 0.62–0.76). Performance was lower than that of procalcitonin and NEWS2 but comparable to C-reactive protein and lactate. DLL-1 showed a moderate correlation with SOFA score. Importantly, correlations with CRP and white blood cell count were nonsignificant.

Conclusions

When measured at ED presentation, DLL-1 concentrations are elevated in patients with sepsis but showed only moderate diagnostic performance. These findings are consistent with earlier disease stages and lower degrees of organ dysfunction compared with ICU populations. DLL-1 may offer complementary host-response information beyond established biomarkers, but does not support stand-alone use for early sepsis diagnosis and warrants further evaluation within multimodal risk stratification strategies.

Trial registration.

DRKS00017395.